Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer

Showing results (211-220 of 41,508) with videos related to

Pageof 4,151
Sort By:
Cancer|June 22, 2010
Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapyAbha A Gupta, Alberto Pappo, Natasha Saunders, et al.
Cancer|June 22, 2010
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 yearsChad R Tracy, Jay D Raman, Chester Donnally, et al.
Cancer|June 22, 2010
Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single centerAndre Meier, Imke Satzger, Bernward Völker, et al.
Cancer|June 24, 2010
The antitumor activity of NK012, an SN-38-incorporating micelle, in combination with bevacizumab against lung cancer xenograftsHirotsugu Kenmotsu, Masahiro Yasunaga, Koichi Goto, et al.
Cancer|June 24, 2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimenDeborah Thomas, Susan O'Brien, Stefan Faderl, et al.
Cancer|June 24, 2010
Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experienceDouglas E Ney, Anne S Reiner, Katherine S Panageas, et al.
Cancer|June 24, 2010
Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphomaGreg Dueck, Neil Chua, Angeli Prasad, et al.
Cancer|June 22, 2010
Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancerMarkus Becker, Tibor Szarvas, Markus Wittschier, et al.
Cancer|August 4, 2010
22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinomaWunchana Seubwai, Chaisiri Wongkham, Anucha Puapairoj, et al.
Cancer|August 4, 2010
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaBrian M Slomovitz, Karen H Lu, Taren Johnston, et al.
Pageof 4,151

Showing results (211-220 of 41,508) with videos related to

Sort By:
Pageof 4,151
Cancer|June 22, 2010
Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapyAbha A Gupta, Alberto Pappo, Natasha Saunders, et al.
Cancer|June 22, 2010
Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 yearsChad R Tracy, Jay D Raman, Chester Donnally, et al.
Cancer|June 22, 2010
Comparison of classification systems in melanoma sentinel lymph nodes--an analysis of 697 patients from a single centerAndre Meier, Imke Satzger, Bernward Völker, et al.
Cancer|June 24, 2010
The antitumor activity of NK012, an SN-38-incorporating micelle, in combination with bevacizumab against lung cancer xenograftsHirotsugu Kenmotsu, Masahiro Yasunaga, Koichi Goto, et al.
Cancer|June 24, 2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimenDeborah Thomas, Susan O'Brien, Stefan Faderl, et al.
Cancer|June 24, 2010
Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experienceDouglas E Ney, Anne S Reiner, Katherine S Panageas, et al.
Cancer|June 24, 2010
Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphomaGreg Dueck, Neil Chua, Angeli Prasad, et al.
Cancer|June 22, 2010
Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancerMarkus Becker, Tibor Szarvas, Markus Wittschier, et al.
Cancer|August 4, 2010
22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinomaWunchana Seubwai, Chaisiri Wongkham, Anucha Puapairoj, et al.
Cancer|August 4, 2010
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaBrian M Slomovitz, Karen H Lu, Taren Johnston, et al.
Pageof 4,151